Over the past year there were no insider purchases at BeOne Medicines Ltd.. 11 insiders sold roughly $368.9 million instead.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
On the institutional side, 282 funds reported holding ONC at the end of Q2 2026, and more funds bought than sold. 7 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Lee Chan Henry | Executive Officer | Sell | 1,115 | $375.00 | $418K | SEC |
| Sep 30, 2026 | Wang Xiaodong | Director | Sell | 160 | $356.97 | $57K | SEC |
| Sep 30, 2026 | Wang Xiaodong | Director | Sell | 120 | $358.71 | $43K | SEC |
| Sep 30, 2026 | Wang Xiaodong | Director | Sell | 40 | $359.16 | $14K | SEC |
| Sep 30, 2026 | Wang Xiaodong | Director | Sell | 2,241 | $361.05 | $809K | SEC |
| Sep 30, 2026 | Wang Xiaodong | Director | Sell | 738 | $367.23 | $271K | SEC |
| Sep 30, 2026 | Wang Xiaodong | Director | Sell | 3,499 | $363.10 | $1.3M | SEC |
| Sep 30, 2026 | Wang Xiaodong | Director | Sell | 3,419 | $364.07 | $1.2M | SEC |
| Sep 30, 2026 | Wang Xiaodong | Director | Sell | 2,047 | $365.85 | $749K | SEC |
| Sep 30, 2026 | Wang Xiaodong | Director | Sell | 14,525 | $366.58 | $5.3M | SEC |
| Sep 30, 2026 | Wang Xiaodong | Director | Sell | 4,239 | $362.17 | $1.5M | SEC |
| Sep 10, 2026 | Wang Xiaodong | Director | Sell | 10,688 | $349.28 | $3.7M | SEC |
| Sep 10, 2026 | Wang Xiaodong | Director | Sell | 7,492 | $348.31 | $2.6M | SEC |
| Sep 10, 2026 | Wang Xiaodong | Director | Sell | 6,569 | $350.27 | $2.3M | SEC |
| Sep 10, 2026 | Wang Xiaodong | Director | Sell | 1,517 | $347.39 | $527K | SEC |
In the last 12 months BeOne Medicines Ltd. insiders made open-market purchases worth about $0 and sales worth about $368.9 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ONC was filed on 2026-10-02.
282 investment managers reported holding ONC in SEC Form 13F filings for Q2 2026.
No congressional trades in ONC were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).